Skip to main navigation Skip to search Skip to main content

Psychiatric disorders newly diagnosed among veterans subsequent to hospitalization for COVID-19

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The goal of our study was to evaluate the development of new mental health diagnoses up to 6-months following COVID-19 hospitalization for in a large, national sample. Method: Data were extracted for all Veterans hospitalized at Veterans Health Administration hospitals for COVID-19 from March through August of 2020 utilizing national administrative data. After identifying the cohort, follow-up data were linked through six months post-hospitalization. Data were analyzed using logistic regression. Results: Eight percent of patients developed a new mental health diagnosis following hospitalization. The most common new mental health diagnoses involved depressive, anxiety, and adjustment disorders. Younger and rural patients were more likely to develop new mental health diagnoses. Women and those with more comorbidities were less likely to develop new diagnoses. Conclusion: A subpopulation of patients hospitalized for COVID-19 developed new mental health diagnoses. Unique demographics predictors indicate the potential need for additional outreach and screening to groups at elevated risk of post-hospitalization, mental health sequelae.

Original languageEnglish (US)
Article number114570
JournalPsychiatry Research
Volume312
DOIs
StatePublished - Jun 1 2022

Funding

This work was supported by funding from the US Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Service awards (COVID19–20–208; SDR17–155 and SDR18–321; PI: Hynes). Dr. Chen is currently funded by a VA Health Services Research & Development Career Development Award (CDA 18–185). Dr. Govier was funded by a VA Advanced Fellowship in Health Services Research & Development (TPH 98–000–02) through the VA Office of Academic Affiliations. We appreciate the guidance of colleagues who served on our COVID-19 Sequelae Clinical Epidemiology Advisory Committee including Mary Whooley, MD, FACP, FAHA, FACC, FAMIA, Michael Matheny, MD, MS, MPH, Karen Saban, PhD, RN, APRN, CNRN, FAHA, FAAN, Jeffrey Bethel, PhD, and Javier Nieto, MD, PhD, MPH, MHS,. We also wish to acknowledge Alan Teo, MD, MS, who was involved in early discussions regarding mental health outcomes and COVID-19. This work was supported by funding from the US Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Service awards (COVID19–20–208; SDR17–155 and SDR18–321; PI: Hynes). Dr. Chen is currently funded by a VA Health Services Research & Development Career Development Award (CDA 18–185). Dr. Govier was funded by a VA Advanced Fellowship in Health Services Research & Development (TPH 98–000–02) through the VA Office of Academic Affiliations.

FundersFunder number
CNRN
FACC
FACP
FAHA
FAMIA
U.S. Department of Veterans AffairsIK6HX003395
Food Allergy and Anaphylaxis NetworkCOVID-19
Health Services Research and DevelopmentSDR18–321, CDA 18–185, COVID19–20–208, SDR17–155, TPH 98–000–02
Office of Academic Affiliations, Department of Veterans Affairs

    Keywords

    • Covid-19
    • Intensive care
    • Mental health
    • Military veterans

    ASJC Scopus subject areas

    • Psychiatry and Mental health
    • Biological Psychiatry

    Fingerprint

    Dive into the research topics of 'Psychiatric disorders newly diagnosed among veterans subsequent to hospitalization for COVID-19'. Together they form a unique fingerprint.

    Cite this